Histogen’s method of generating multipotent stem cells receives US patent

September 5, 2013

The issued patent covers Histogen’s method of triggering the de-differentiation of fibroblast cells into multipotent stem cells through low oxygen and special culture conditions. The resulting multipotent cells naturally secrete a variety of soluble and insoluble molecules that are the basis for Histogen’s products. (Medical News Today)